Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Linagliptin on Endothelial, Renal, and Retinal Function in Patients with Hypertension and Albuminuria
2012-004300-35Phase 3Completed
- Sponsor
- Profil
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Arterionephrosclerosis (ANS) and albuminuria comparing Linagliptin (Trajenta) with Placebo (2 arms). Primary endpoint: Primary. Started Dec 2012; status: completed.
02
Drugs
linagliptin
03
Conditions
Arterionephrosclerosis (ANS)albuminuria
Beyond the preview
Go deeper on 2012-004300-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004300-35.